Ensysce Biosciences Inc (ENSC) — Financial Flexibility Index
Ensysce Biosciences Inc (ENSC) has a Financial Flexibility Index of -0.31x as of December 2025. Free cash flow of $-1.40 Million (operating CF $-1.53 Million minus capex $123.64K) represents 0% of total liabilities ($4.57 Million). Also explore ENSC net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ensysce Biosciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Ensysce Biosciences Inc across 9 annual periods. Check how strategically is Ensysce Biosciences Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ensysce Biosciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Ensysce Biosciences Inc. For the full company profile including market capitalisation, see Ensysce Biosciences Inc (ENSC) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.71x | $-7.81 Trillion | $-7.81 Trillion | $4.57 Trillion | ▲ +100.0% |
| 2024 | -3383720.60x | $-7.50 Trillion | $-7.50 Trillion | $2.22 Million | ▼ -105446371.7% |
| 2023 | -3.21x | $-10.78 Million | $-10.78 Million | $3.36 Million | ▼ -77.9% |
| 2022 | -1.80x | $-17.89 Million | $-17.89 Million | $9.91 Million | ▼ -437.9% |
| 2021 | -0.34x | $-8.24 Million | $-8.24 Million | $24.58 Million | ▼ -88.5% |
| 2020 | -0.18x | $-1.25 Million | $-1.25 Million | $7.01 Million | ▼ -116.7% |
| 2019 | 1.06x | $10.99 Million | $10.99 Million | $10.34 Million | ▲ +739.0% |
| 2018 | -0.17x | $-1.24 Million | $-1.24 Million | $7.44 Million | ▼ -373.0% |
| 2017 | -0.04x | $-251.83K | $-251.83K | $7.16 Million | — |